| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| AGB01434.1 | AGB02040.1 | Metfor_0360 | Metfor_0988 | Putative NADPH-quinone reductase (modulator of drug activity B); PFAM: Flavodoxin-like fold. | PFAM: Ion channel. | 0.856 |
| AGB01434.1 | AGB02059.1 | Metfor_0360 | Metfor_1007 | Putative NADPH-quinone reductase (modulator of drug activity B); PFAM: Flavodoxin-like fold. | Kef-type K+ transport system, predicted NAD-binding component; PFAM: TrkA-N domain; Sodium/hydrogen exchanger family; TrkA-C domain; TIGRFAM: transporter, monovalent cation:proton antiporter-2 (CPA2) family. | 0.794 |
| AGB01434.1 | AGB02303.1 | Metfor_0360 | Metfor_1260 | Putative NADPH-quinone reductase (modulator of drug activity B); PFAM: Flavodoxin-like fold. | Kef-type K+ transport system, predicted NAD-binding component; PFAM: TrkA-N domain; TrkA-C domain; Sodium/hydrogen exchanger family; TIGRFAM: transporter, monovalent cation:proton antiporter-2 (CPA2) family. | 0.794 |
| AGB01434.1 | AGB03730.1 | Metfor_0360 | Metfor_2745 | Putative NADPH-quinone reductase (modulator of drug activity B); PFAM: Flavodoxin-like fold. | Kef-type K+ transport system, membrane component; PFAM: TrkA-N domain; Sodium/hydrogen exchanger family; TrkA-C domain. | 0.794 |
| AGB01779.1 | AGB02040.1 | Metfor_0719 | Metfor_0988 | NhaP-type Na+(K+)/H+ antiporter; PFAM: Sodium/hydrogen exchanger family; TrkA-C domain. | PFAM: Ion channel. | 0.854 |
| AGB01779.1 | AGB02059.1 | Metfor_0719 | Metfor_1007 | NhaP-type Na+(K+)/H+ antiporter; PFAM: Sodium/hydrogen exchanger family; TrkA-C domain. | Kef-type K+ transport system, predicted NAD-binding component; PFAM: TrkA-N domain; Sodium/hydrogen exchanger family; TrkA-C domain; TIGRFAM: transporter, monovalent cation:proton antiporter-2 (CPA2) family. | 0.881 |
| AGB01779.1 | AGB02298.1 | Metfor_0719 | Metfor_1255 | NhaP-type Na+(K+)/H+ antiporter; PFAM: Sodium/hydrogen exchanger family; TrkA-C domain. | Na+/H+ antiporter NhaD-like permease; PFAM: Citrate transporter. | 0.587 |
| AGB01779.1 | AGB02303.1 | Metfor_0719 | Metfor_1260 | NhaP-type Na+(K+)/H+ antiporter; PFAM: Sodium/hydrogen exchanger family; TrkA-C domain. | Kef-type K+ transport system, predicted NAD-binding component; PFAM: TrkA-N domain; TrkA-C domain; Sodium/hydrogen exchanger family; TIGRFAM: transporter, monovalent cation:proton antiporter-2 (CPA2) family. | 0.881 |
| AGB01779.1 | AGB03730.1 | Metfor_0719 | Metfor_2745 | NhaP-type Na+(K+)/H+ antiporter; PFAM: Sodium/hydrogen exchanger family; TrkA-C domain. | Kef-type K+ transport system, membrane component; PFAM: TrkA-N domain; Sodium/hydrogen exchanger family; TrkA-C domain. | 0.881 |
| AGB02040.1 | AGB01434.1 | Metfor_0988 | Metfor_0360 | PFAM: Ion channel. | Putative NADPH-quinone reductase (modulator of drug activity B); PFAM: Flavodoxin-like fold. | 0.856 |
| AGB02040.1 | AGB01779.1 | Metfor_0988 | Metfor_0719 | PFAM: Ion channel. | NhaP-type Na+(K+)/H+ antiporter; PFAM: Sodium/hydrogen exchanger family; TrkA-C domain. | 0.854 |
| AGB02040.1 | AGB02059.1 | Metfor_0988 | Metfor_1007 | PFAM: Ion channel. | Kef-type K+ transport system, predicted NAD-binding component; PFAM: TrkA-N domain; Sodium/hydrogen exchanger family; TrkA-C domain; TIGRFAM: transporter, monovalent cation:proton antiporter-2 (CPA2) family. | 0.622 |
| AGB02040.1 | AGB02303.1 | Metfor_0988 | Metfor_1260 | PFAM: Ion channel. | Kef-type K+ transport system, predicted NAD-binding component; PFAM: TrkA-N domain; TrkA-C domain; Sodium/hydrogen exchanger family; TIGRFAM: transporter, monovalent cation:proton antiporter-2 (CPA2) family. | 0.621 |
| AGB02040.1 | AGB03730.1 | Metfor_0988 | Metfor_2745 | PFAM: Ion channel. | Kef-type K+ transport system, membrane component; PFAM: TrkA-N domain; Sodium/hydrogen exchanger family; TrkA-C domain. | 0.618 |
| AGB02059.1 | AGB01434.1 | Metfor_1007 | Metfor_0360 | Kef-type K+ transport system, predicted NAD-binding component; PFAM: TrkA-N domain; Sodium/hydrogen exchanger family; TrkA-C domain; TIGRFAM: transporter, monovalent cation:proton antiporter-2 (CPA2) family. | Putative NADPH-quinone reductase (modulator of drug activity B); PFAM: Flavodoxin-like fold. | 0.794 |
| AGB02059.1 | AGB01779.1 | Metfor_1007 | Metfor_0719 | Kef-type K+ transport system, predicted NAD-binding component; PFAM: TrkA-N domain; Sodium/hydrogen exchanger family; TrkA-C domain; TIGRFAM: transporter, monovalent cation:proton antiporter-2 (CPA2) family. | NhaP-type Na+(K+)/H+ antiporter; PFAM: Sodium/hydrogen exchanger family; TrkA-C domain. | 0.881 |
| AGB02059.1 | AGB02040.1 | Metfor_1007 | Metfor_0988 | Kef-type K+ transport system, predicted NAD-binding component; PFAM: TrkA-N domain; Sodium/hydrogen exchanger family; TrkA-C domain; TIGRFAM: transporter, monovalent cation:proton antiporter-2 (CPA2) family. | PFAM: Ion channel. | 0.622 |
| AGB02059.1 | AGB02064.1 | Metfor_1007 | Metfor_1012 | Kef-type K+ transport system, predicted NAD-binding component; PFAM: TrkA-N domain; Sodium/hydrogen exchanger family; TrkA-C domain; TIGRFAM: transporter, monovalent cation:proton antiporter-2 (CPA2) family. | K+ transport system, NAD-binding component; PFAM: TrkA-N domain; TrkA-C domain. | 0.628 |
| AGB02059.1 | AGB02298.1 | Metfor_1007 | Metfor_1255 | Kef-type K+ transport system, predicted NAD-binding component; PFAM: TrkA-N domain; Sodium/hydrogen exchanger family; TrkA-C domain; TIGRFAM: transporter, monovalent cation:proton antiporter-2 (CPA2) family. | Na+/H+ antiporter NhaD-like permease; PFAM: Citrate transporter. | 0.604 |
| AGB02059.1 | AGB02303.1 | Metfor_1007 | Metfor_1260 | Kef-type K+ transport system, predicted NAD-binding component; PFAM: TrkA-N domain; Sodium/hydrogen exchanger family; TrkA-C domain; TIGRFAM: transporter, monovalent cation:proton antiporter-2 (CPA2) family. | Kef-type K+ transport system, predicted NAD-binding component; PFAM: TrkA-N domain; TrkA-C domain; Sodium/hydrogen exchanger family; TIGRFAM: transporter, monovalent cation:proton antiporter-2 (CPA2) family. | 0.774 |